Clinical Trial Update: AngioJET Thrombectomy and STENTing for Treatment of Acute Myocardial Infarction [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update on AngioJET thrombectomy with stenting for acute myocardial infarction, conducted by Boston Scientific, has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• AngioJET Thrombectomy

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Myocardial Infarction | Phase 4 | Status: COMPLETED